Form 4: Accelerate Diagnostics Director Mark S. Black Receives 66,667 Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Director Mark S. Black of Accelerate Diagnostics, Inc. was granted 66,667 restricted stock units (RSUs) on May 20, 2024, which vest on the first anniversary of the grant date, with deferred receipt of shares until departure from the board.

Summary

  • On May 21, 2024, a Form 4 filing was submitted to the SEC regarding Mark S. Black, a director of Accelerate Diagnostics, Inc.
  • The filing reports that on May 20, 2024, Mr. Black was granted 66,667 restricted stock units (RSUs).
  • These RSUs represent a contingent right to receive one share of Accelerate Diagnostics' common stock upon vesting.
  • The RSUs vest on the first-year anniversary of the grant date, with pro-rata vesting if the reporting person leaves in good standing before such vesting date.
  • Mr. Black has elected to defer receipt of the shares of common stock upon vesting of the RSUs until within 30 days following his departure from the board of directors, pursuant to the issuer's Director Equity Deferral Program.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reflects a standard compensation practice. The grant of RSUs is generally viewed positively as it aligns director interests with shareholders, but it's not a major event.

Positives

  • The grant of RSUs to a director aligns their interests with those of the shareholders.
  • The vesting schedule encourages continued service on the board.

Future Outlook

The director will receive shares of common stock upon vesting of the RSUs, with the actual timing dependent on his continued service and departure from the board.

Industry Context

Grants of restricted stock units are a common form of executive compensation in publicly traded companies, aligning the interests of directors and management with those of shareholders.

Stakeholder Impact

  • The grant of RSUs aligns the director's interests with those of shareholders, potentially encouraging decisions that increase shareholder value.

Key Dates

DateDescription
05/20/2024Date of transaction: Grant of 66,667 Restricted Stock Units (RSUs).
05/21/2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.